17-10-19 | 10:30 - 11:30 AM CET

How can I access the Japanese market as a novel biopharmaceutical product's owner?

Japan includes a huge market for biopharmaceutical products which is open for innovative products and services, also those from abroad. Current trends are in immunotherapeuticals, cell-based products and genomic medicine. Japanese regulations favour innovative products and services and thus may offer an opportunity for fast-track market access. In view of specific rules and regulations, however, it may be advantageous for European SMEs to team up with Japanese or international marketing authorisation holders (MAHs).

The webinar is targeted to EU companies seeking to export their innovative biopharmaceutical products or services to Japan.

Registration deadline: 16/10/2019

In 40 minutes from your desk, discover how to:

• Position your product or service in the existing Japanese biopharmaceutical market
• Assess if you qualify for an innovative product or service to earn "forerunner benefits"
• Approach the Japanese market through appropriate marketing authorization holders (MAHs)
• Meet MAHs and other relevant stakeholders

Programme:

• Introduction
• Expert’s presentation
• Q&A Session
• Conclusion

Speakers: Rolf Schmid - Bio4Business  

Organiser: EU-Japan Centre for Industrial Cooperation - Brussels Office 

Please go to the EU Business in Japan website, to register for this webinar.

If you are already a member of the EU Business in Japan website, please log in and then go to the webinar link - If you are not yet a member, you will first have to register as a member via:http://www.eubusinessinjapan.eu/user/register and then when your registration request is confirmed, please log in and go to the 'Events' section of the website and register to the webinar.